vignette

Chapter 3 - The Ghost in the Ledgers

By midnight, the executive floor was silent except for the hum of the fluorescent lights in the corner conference room. Raymond Vance, Julian, and a team of three forensic accountants were surrounded by mountains of red-labeled folders, banking statements, and flashing terminal screens.

I sat with a mug of black coffee that had gone cold hours ago. Beside me lay Barnaby, the pink stuffed rabbit whose ear still bore the faint scent of Chloe’s baby shampoo. Every time my heart threatened to shatter under the weight of my grief, I touched that soft ear and remembered why I was sitting here.

"Claire," Julian said softly, rolling his chair over to mine. "You need to see this."

He turned his laptop toward me. A complex financial schematic appeared on the screen, mapping twelve major capital outflows spanning the last eighteen months.

"At first, we thought Arthur was simply embezzling to fund his lifestyle with Beatrice," Julian explained, tapping a key to highlight several nodes in bright crimson. "The five-million-dollar penthouse in Miami, the private yacht charters, the jewelry. But that accounts for only four million. There's forty-two million dollars unaccounted for."

"Where did it go?" I asked, leaning in.

"That's the strange part. It wasn't invested in tech, real estate, or stocks. It was wired in twelve separate tranches to a pharmaceutical research incubator in Switzerland called *Aethelgard Bio*."

I frowned. "Sterling Holdings doesn't invest in biotechnology. My father explicitly forbade it in the corporate charter after a bad venture in the nineties."

"Arthur circumvented the charter by routing the money through shell logistics firms," Julian said. "He disguised them as procurement contracts for office supplies, software licensing, and shipping logistics."

Raymond adjusted his glasses, walking over with a printed legal affidavit. "What makes this chilling, Claire, is the patent filings. We had our Swiss liaison pull the corporate registry of Aethelgard Bio this afternoon. Arthur owns eighty percent of it under an anonymous trust. And do you know what they were developing?"

"Tell me, Raymond."

"A proprietary pediatric antibody treatment. Specifically designed for rare auto-immune and bacterial infections in early childhood."

My breath caught in my throat. The room seemed to tilt beneath my feet. "What did you say?"

"Aethelgard Bio was developing an experimental biologic for pediatric meningitis and neurological inflammation," Raymond whispered. "Arthur wasn't just stealing company money. He was funneling it into an unapproved, highly speculative medical venture."

"Why?" I asked, my voice rising with sudden, terrifying dread. "Arthur didn't care about medicine. He barely knew what vitamins Chloe took. Why would he risk his entire life to fund a meningitis research company?"

Julian swallowed hard, exchanging an uneasy look with Raymond.

"Julian," I commanded, "tell me everything. Right now."

"Claire... three weeks ago, Aethelgard Bio failed its Phase II clinical safety trials. The Swiss regulatory authorities issued an immediate shutdown order due to severe toxicity markers. The entire forty-two million dollars vanished overnight. Arthur was completely ruined. He was facing total financial exposure."

"And what did he do to cover it?"

Julian clicked another folder open on the screen, revealing an encrypted email thread between Arthur and a private insurance underwriter in Bermuda dated four weeks before Chloe fell ill.

"Arthur took out a private key-person life policy," Julian whispered, his hands trembling. "Not on an executive. Not on himself."

He scrolled down to the signature line of the policy application.

May you like

The insured party was Chloe Pendelton. The payout sum was fifty million dollars.

***

Related Stories

Other posts